NCT06312644 2026-04-16Study of UltomirisĀ® (Ravulizumab) Safety in PregnancyAlexion Pharmaceuticals, Inc.Recruiting75 enrolled
NCT06967480 2026-02-05Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia GravisAlexion Pharmaceuticals, Inc.Recruiting40 enrolled